Cellular Therapies
Cells intended for the transplantation of hematopoietic progenitors, cellular therapies, or the manufacture of advanced therapy medicinal products
The Cellular Therapy Service of the BST aims to prepare therapeutic cells for hematopoietic stem cell transplantation to treat diseases such as leukaemias or lymphomas, other cellular therapies, or the manufacture of advanced therapy medicinal products. These cells are obtained from voluntary or directed donations, processed, stored, and supplied to hospitals for administration to patients.
The Cellular Therapy Service has 3 areas:
- Cell Banks consist of lists of Donors' data (Registries) or collections of their donated cells (Banks) so that they can be selected based on the best option according to compatibility in a recipient. The STC has the Barcelona Cord Blood Bank, the REDMO registry, and the ReDoCel registry, as well as the IPS-PANIA iPSC bank.
- Clinical and Laboratory Services of Cellular Therapy: in these services, at the time of donation, the patient who will receive the cellular therapy is already known, as well as the necessary processes to prepare it. The stages include cell collection, processing, storage, distribution, and delivery.
- Research is focused on the development of new products and the improvement of transplantation and its immunological monitoring.
Healthcare professional, you need to place an order
To place orders and requests, you need to access the tool within the Private Area. You can access it from here or, if you have any questions or queries, please contact us.
subministrament@bst.catÚltimes novetats
Advanced Therapies
Advanced therapies are characterized by using genes, tissues, or human cells that are manipulated to turn them into a medicine.